MicroRNA Therapeutics in Triple Negative Breast Cancer
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 009-017
- https://doi.org/10.29328/journal.hjpcr.1001003
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- The Role of MicroRNAs in Breast Cancer Stem CellsInternational Journal of Molecular Sciences, 2013
- Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1Tumor Biology, 2013
- Analysis of serum genome-wide microRNAs for breast cancer detectionClinica Chimica Acta; International Journal of Clinical Chemistry, 2012
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer NetworkCancer, 2012
- Down‐regulation of BRCA1 expression by miR‐146a and miR‐146b‐5p in triple negative sporadic breast cancersEMBO Molecular Medicine, 2011
- Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cellsBiochemical Pharmacology, 2011
- The Roles of MicroRNAs in the Cancer Invasion-Metastasis CascadeCancer Microenvironment, 2010
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaLaboratory Investigation, 2005